-
Symbol
-
CADL on Nasdaq
-
Investment type
-
Equity / Common Stock, $0.01 par value per share
-
Latest Disclosed Shares Owned
-
2,580,517 shares
-
Security Ownership %
-
5.2%
Anders Hove ownership in Candel Therapeutics, Inc. Common Stock, $0.01 par value per share (CADL)
30 Jun 2025 - Anders Hove has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 2,580,517 shares of Candel Therapeutics, Inc. Common Stock, $0.01 par value per share (CADL).
This represents 5.2% ownership of the company.
This is the first filing by ACORN BIOVENTURES, L.P. disclosing ownership of Candel Therapeutics, Inc. Common Stock, $0.01 par value per share (CADL).